Innovation and Disruption

April 26—Senior Trump administration officials are likely to tout their efforts to support innovations in healthcare delivery during presentations next week at a Washington, D.C., health policy event. Some of the areas they still need to address came up in Congress this week.

The recently announced Amazon-Berkshire Hathaway-JPMorgan Chase affiliation has been widely discussed an important development in health care, but it would not likely have enough control and leverage to bring about meaningful change.

Reduced utilization of hospitals has many calling their future usefulness into question.

Healthcare joint ventures involving U.S. corporations, such as one announced by Amazon, Berkshire Hathaway, JPMorgan Chase, could significantly disrupt the nation's healthcare system.

HFMA/Deloitte research reveals the importance of cultural alignment to successful hospital mergers.

Feb. 28—Although little is yet clear about the high-profile collaboration between three innovative companies, hospitals could see a range of impacts, industry watchers say.

Feb. 27—Executives at CVS Health and Aetna told Congress this week that the merged entity they propose to create will look to garner savings from reduced hospital use.

Feb. 22—Congress will take a look this week at one of the new breed of mergers that are shaking up the healthcare industry.

By partnering with all stakeholders, exploring and advancing new technologies, and fostering collaboration, Change Healthcare helps providers and payers navigate the transforming healthcare marketplace—aiming to enable a new paradigm in which health care is more efficient, effective, and patient-centric.

Hospitals and health systems are challenged to respond strategically to disruptive new competitors and technologies that are entering their markets and threaten to dramatically transform the industry.